药物所致医源性男性不育的综述
该综述聚焦于导致医源性男性不育的常见药物,指出对男性不育患者必须详细询问用药史,以明确是否正在或曾经暴露于损害性欲、精子发生、射精或下丘脑-垂体-睾酮轴的药物,并讨论减少或逆转其影响的方案。
要点
- 男性不育评估应详细追溯当前及既往用药史。
- 药物可损害性欲、精子发生、射精及下丘脑-垂体-睾酮轴。
- 综述汇总常见致病药物及减轻或逆转其影响的方案。
核心结论
- 部分常用药物可导致医源性男性不育,临床需识别并考虑减量或逆转方案。
研究设计与样本
- 综述,检索范围与样本量原文未报告。
主要发现
- 药物可经损害性欲、精子发生、射精或下丘脑-垂体-睾酮轴等途径影响男性生育。
临床怎么用
- 对男性不育患者应详细询问当前及既往用药,以识别可致不育的药物暴露。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Primum non nocere. As physicians, our goal is to treat illnesses and alleviate suffering; however, in doing so, we can generate new problems in a game of medical whack-a-mole. For some patients, certain consequences or side effects are tolerable, while others may believe they have no alternative. For a male patient with infertility, a thorough history is imperative to elucidate whether the patient has been or is currently being exposed to medications that will harm libido, spermatogenesis, ejaculation, or the hypothalamic-pituitary-testosterone axis. This article will review the most common medications causing iatrogenic male infertility as well as options to minimize or even reverse their impact.
引用
- Velez D, Ohlander S. Medical therapies causing iatrogenic male infertility. Fertil Steril. 2021. PMID: 34462096. doi:10.1016/j.fertnstert.2021.07.1202
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。